Streetbeat News

Products Services

CSTF

CuraScientific Corp. (OTCPK:CSTF) has partnered with My Green Network to showcase and distribute their cannabis products in Santa Ana, California. The agreement will allow CuraScientific to expand their distribution routes to cover the entire Inland Empire and Orange County. The CEO of CuraScientific believes that California, and specifically Orange County, offers a profitable cannabis revenue due to its untapped market for retail cannabis sales.

Portfolio Pulse from Vuk Zdinjak

June 28, 2023 | 12:57 pm

QCOM

Qualcomm and MediaTek are competing to develop 4nm technology for their midrange and low-end smartphone SoCs.

Portfolio Pulse from Benzinga Newsdesk

June 28, 2023 | 12:56 pm

TSLA

Volvo Car has announced a deal to allow its electric car drivers to access Tesla Inc.’s network of 12,000 superchargers across the U.S., Canada, and Mexico. Volvo will equip its new cars with a North American Charging Standard (NACS) port from 2025, and current electric-car drivers will be able to access the Tesla network from the first half of 2024 with an adaptor. This follows similar agreements by Ford Motor and General Motors with Tesla.

Portfolio Pulse from Benzinga Newsbot

June 28, 2023 | 12:51 pm

GDYN

Grid Dynamics Holdings, Inc. (NASDAQ:GDYN) has launched an AI Focus Groups Starter Kit, a generative AI solution aimed at helping enterprises analyze user-generated content and optimize social media campaigns more efficiently and at a lower cost. The kit uses large language models to analyze customer reviews, social media posts, comments, and other types of user-generated content and events, creating AI focus groups composed of virtual personas that match the behavior of a brand's real-world target audience.

Portfolio Pulse from Happy Mohamed

June 28, 2023 | 12:50 pm

RCAT

Red Cat Holdings' subsidiary, Teal Drones, has secured an additional $1.2 million in funding for the U.S. Army's Short Range Reconnaissance (SRR) program. This brings the total funding for Teal's participation to $2.7 million. Teal is one of three vendors competing in the final tranche of the SRR program. The winning vendor will produce a rucksack-portable sUAS to provide Army platoons with a rapidly deployable surveillance and reconnaissance capability.

Portfolio Pulse from Happy Mohamed

June 28, 2023 | 12:47 pm

JAGX

Napo Pharmaceuticals, a subsidiary of Jaguar Health, Inc. (NASDAQ:JAGX), has submitted an Investigational New Drug (IND) application to the FDA for a new formulation of crofelemer powder for oral solution for the treatment of microvillus inclusion disease (MVID). The disease is a life-threatening and ultra-rare autosomal recessive disease that affects newborns and children. Crofelemer has been granted Orphan Drug Designation (ODD) by the FDA and the European Medicines Agency (EMA) for MVID and short bowel syndrome (SBS).

Portfolio Pulse from Happy Mohamed

June 28, 2023 | 12:39 pm

RSLS

ReShape Lifesciences Inc. (NASDAQ:RSLS) presented data on its proprietary Diabetes Bloc-Stim Neuromodulation (DBSN) device at the ASMBS 2023 Annual Meeting. The device selectively modulates vagal block and stimulation to the liver and pancreas to manage blood glucose. The company's CEO, Paul F. Hickey, stated that the DBSN device has the potential to deliver personalized therapy by adjusting insulin production, thus potentially reducing dependence on medication.

Portfolio Pulse from Happy Mohamed

June 28, 2023 | 12:38 pm

CLRB

Cellectar Biosciences, Inc. (NASDAQ:CLRB) presented interim data from its ongoing study of iopofosine I 131 in multiple myeloma at the SNMMI Annual Meeting. The data showed an overall response rate of 28%, a clinical benefit rate of 70%, and a disease control rate of 92% in 64 evaluable patients. The company's COO, Jarrod Longcor, highlighted the outcomes from two dose levels across these highly refractory patients. The FDA has granted Fast Track and Orphan Drug Designations for iopofosine in patients with r/r MM.

Portfolio Pulse from Happy Mohamed

June 28, 2023 | 12:37 pm

GNPX

Genprex has received Fast Track Designation from the U.S. FDA for its REQORSA immunogene therapy. The therapy, used in combination with Tecentriq, is for the treatment of small cell lung cancer.

Portfolio Pulse from Benzinga Newsdesk

June 28, 2023 | 12:35 pm

ANSS

SSNLF

Ansys (NASDAQ:ANSS) has achieved certification of its RedHawk-SC and Totem power integrity signoff solutions for Samsung's (SSNLF) latest 2nm silicon process technology. The certification will boost confidence in early adopters of Samsung's technology, creating leading-edge integrated circuits in high-performance computing, smartphones, AI accelerators, data center communication, and graphics processors.

Portfolio Pulse from Happy Mohamed

June 28, 2023 | 12:35 pm